HIV-Related Stigma Intervention for Malaysian Clinicians

Not Applicable

Completed

• Conditions: Hiv
• Interventions: Behavioral: Project ECHO for HIV Prevention; Behavioral: HIV Connect; Behavioral: Project ECHO for HIV Prevention and Stigma Reduction

• Registration Number: NCT05597787
• Lead Sponsor: University of Delaware

Brief Summary

Key populations at risk of HIV (including men who have sex with men, people who inject drugs, transgender women, and female sex workers) are more likely to be infected with HIV but less likely than members of the general population to know of their HIV status, receive HIV prevention counseling, or be linked to HIV care services. Clinician stigma towards these groups remains a potent and persistent driver of these HIV disparities in many places of the world. The investigators propose to incorporate evidence-based stigma reduction tools into a popular teletraining platform for clinicians and pilot test the resulting intervention (Project ECHO® for HIV Prevention and Stigma Reduction) with clinicians in Malaysia, a context wherein clinician stigma and HIV disparities are substantial.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2022-07-25
• Study Start: 2022-07-26
• Study First Submitted QC: 2022-10-24
• Study First Posted: 2022-10-28
• Primary Completion: 2023-03-31
• Study Completion: 2023-05-11
• Status Verified: 2024-01
• Results First Submitted: 2024-10-09
• Results First Submitted QC: 2024-11-15
• Last Update Submitted: 2024-11-15
• Results First Posted: 2024-12-11
• Last Update Posted: 2024-12-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 78

Inclusion Criteria

• practicing general practitioner or family medicine specialist in Malaysia

Read More

Exclusion Criteria

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Project ECHO for HIV Prevention	Project ECHO for HIV Prevention	Participants randomized to this condition will receive Project ECHO for HIV Prevention, without added evidence-based stigma reduction tools. Participants will meet with the Project ECHO Hub specialists and their learning community on a bi-weekly basis for 60 minutes over the course of 9 months. Each session will feature a didactic training incorporating standardized procedures for HIV testing, prevention, and/or linkage to care, and patient-case presentation and discussion.
HIV Connect	HIV Connect	Participants randomized to this condition will complete HIV Connect, which is an online course developed by the Malaysian Society of HIV Medicine designed to educate primary care physicians in Malaysia about HIV. It consists of a series of modules featuring HIV infectious disease experts who instruct on topics including epidemiology and natural history of HIV, pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP), sexual history taking and STI testing, and others.
Project ECHO for HIV Prevention + Stigma Reduction	Project ECHO for HIV Prevention and Stigma Reduction	Participants randomized to this condition will receive the Project ECHO for HIV Prevention intervention with added evidence-based stigma reduction tools. Participants will meet with the Project ECHO Hub specialists and their learning community on a bi-weekly basis for 60 minutes over the course of 9 months. Each session will feature a didactic training incorporating standardized procedures for HIV testing, prevention, and/or linkage to care, and patient-case presentation and discussion.

Primary Outcome Measures

Name	Time	Method
Acceptability of Intervention	Month 9 Assessment	Measured with Acceptability of Intervention Measure. Theoretical or possible range of scores is 1-5, and actual range was 3.50-5. Higher scores indicate greater acceptability.
Feasibility of Intervention	Month 9 Assessment	Measured with Feasibility of Intervention Measure. Theoretical or possible range of scores is 1-5, and actual range was 3.25-5. Higher scores indicate greater feasibility.
Stigma Reduction: Prejudice	Month 9 Assessment	Measured with Feelings Thermometers. Positive/Negative affect is measured on 0-100 point scale, with higher scores indicating more prejudice.
Stigma Reduction: Stereotypes	Month 9 Assessment	Measured with subscale of Multidimensional HIV-Related Stigma Scale. Theoretical or possible range of scores is 1-5, and actual range was 1-3.44. Higher scores indicate greater stereotypes.
Stigma Reduction: Discrimination	Month 9 Assessment	Measured with subscale of Multidimensional HIV-Related Stigma Scale. Theoretical or possible range of scores is 1-5, and actual range was 1-5. Higher scores indicate greater discrimination.

Secondary Outcome Measures

Name	Time	Method
HIV Prevention Procedures: PrEP Prescriptions	Cumulative over 9 month intervention	Measured with weekly diary of PrEP prescriptions. Number of PrEP prescriptions will be summed over duration of intervention.
HIV Prevention Procedures: HIV Testing	Cumulative over 9 month intervention	Measured with weekly diary of HIV tests performed. Number of HIV tests will be summed over duration of intervention.

Trial Locations

Locations (1)

University of Malaya; 🇲🇾 Kuala Lumpur, Malaysia